E-LIB Suche - Ergebnisse für: Iwata, Nakao

1

A comparison of recurrence rates after discontinuation of s..:

Kishi, Taro ; Citrome, Leslie ; Sakuma, Kenji.
Psychiatry Research. 333 (2024) - p. 115761 , 2024

Link: https://doi.org/10.1016/..

2

External Validation of a Machine Learning Model for Schizop..:

He, Yupeng ; Sakuma, Kenji ; Kishi, Taro...
Journal of Clinical Medicine. 13 (2024) 10 - p. 2970 , 2024

Link: https://doi.org/10.3390/..

3

Adverse childhood experiences exacerbate peripheral symptom..:

Okumura, Kazuki ; Takeda, Tsutomu ; Komori, Takashi...
Psychiatry and Clinical Neurosciences. , 2024

Link: https://doi.org/10.1111/..

4

Theta burst stimulation for depression: a systematic review..:

Kishi, Taro ; Ikuta, Toshikazu ; Sakuma, Kenji...
Molecular Psychiatry. , 2024

Link: https://doi.org/10.1038/..

5

Acceptability of antipsychotic transdermal patch for acute ..:

Kishi, Taro ; Citrome, Leslie ; Sakuma, Kenji...
Psychiatry and Clinical Neurosciences. 78 (2024) 4 - p. 260-262 , 2024

Link: https://doi.org/10.1111/..

6

Antidepressants available in Japan for older people with ma..:

Kishi, Taro ; Sakuma, Kenji ; Hatano, Masakazu...
Neuropsychopharmacology Reports. 44 (2024) 1 - p. 267-271 , 2024

Link: https://doi.org/10.1002/..

7

Post‐marketing surveillance of quetiapine fumarate extended..:

Kishi, Taro ; Iwata, Nakao ; Irie, Hiroyuki.
Neuropsychopharmacology Reports. 44 (2024) 2 - p. 424-436 , 2024

Link: https://doi.org/10.1002/..

8

Comparison of brexpiprazole, aripiprazole, and placebo for ..:

Kishi, Taro ; Sakuma, Kenji ; Saito, Takeo...
Neuropsychopharmacology Reports. 44 (2024) 1 - p. 165-175 , 2024

Link: https://doi.org/10.1002/..

9

Physical, Psychiatric, and Social Comorbidities of Individu..:

Matsunaga, Masaaki ; Li, Yuanying ; He, Yupeng...
International Journal of Environmental Research and Public Health. 20 (2023) 5 - p. 4336 , 2023

Link: https://doi.org/10.3390/..

10

Newer antidepressant for Japanese adults with major depress..:

Kishi, Taro ; Sakuma, Kenji ; Hatano, Masakazu...
Neuropsychopharmacology Reports. 44 (2023) 1 - p. 216-220 , 2023

Link: https://doi.org/10.1002/..

11

Asenapine add‐on treatment for schizophrenia adults who rec..:

Kishi, Taro ; Iwama, Yasuhiro ; Sasagawa, Yuji...
Psychiatry and Clinical Neurosciences. 77 (2023) 6 - p. 365-366 , 2023

Link: https://doi.org/10.1111/..

12

GWAS-identified bipolar disorder risk allele in the FADS1/2..:

Yamamoto, Hirona ; Lee-Okada, Hyeon-Cheol ; Ikeda, Masashi...
Molecular Psychiatry. 28 (2023) 7 - p. 2848-2856 , 2023

Link: https://doi.org/10.1038/..

13

Repetitive transcranial magnetic stimulation for preventing..:

Matsuda, Yuki ; Sakuma, Kenji ; Kishi, Taro...
Brain Stimulation. 16 (2023) 2 - p. 458-461 , 2023

Link: https://doi.org/10.1016/..

14

Repetitive transcranial magnetic stimulation for mania: A s..:

Kishi, Taro ; Sakuma, Kenji ; Matsuda, Yuki..
Bipolar Disorders. 25 (2023) 2 - p. 160-161 , 2023

Link: https://doi.org/10.1111/..

15

Safety profile of antidepressant for Japanese adults with m..:

Kishi, Taro ; Ikuta, Toshikazu ; Sakuma, Kenji...
Psychiatry and Clinical Neurosciences. 78 (2023) 2 - p. 142-144 , 2023

Link: https://doi.org/10.1111/..